The use of intragenic polymorphisms in determination of the genomic relevance of whole-exon deletions in MLH1 and MSH2

Clin Genet. 2001 Mar;59(3):201-2. doi: 10.1034/j.1399-0004.2001.590311.x.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adaptor Proteins, Signal Transducing
  • Carrier Proteins
  • DNA Mutational Analysis / methods
  • DNA-Binding Proteins*
  • Exons*
  • Germ-Line Mutation
  • Humans
  • MutL Protein Homolog 1
  • MutS Homolog 2 Protein
  • Neoplasm Proteins / genetics*
  • Nuclear Proteins
  • Polymorphism, Genetic
  • Proto-Oncogene Proteins / genetics*
  • Reverse Transcriptase Polymerase Chain Reaction
  • Sequence Analysis, RNA / methods*
  • Sequence Deletion*

Substances

  • Adaptor Proteins, Signal Transducing
  • Carrier Proteins
  • DNA-Binding Proteins
  • MLH1 protein, human
  • Neoplasm Proteins
  • Nuclear Proteins
  • Proto-Oncogene Proteins
  • MSH2 protein, human
  • MutL Protein Homolog 1
  • MutS Homolog 2 Protein